Pfizer Inc.
PFESell · Weight Down
ARK net-sold the stock and the price fell, decreasing its portfolio weight.
Shares -99.9% · Market value -99.9% · Weight -0.02%p
| Date | Action | ETF | Shares | Close | Est. total |
|---|---|---|---|---|---|
| 24.03.12 | SELL | ARKG | 100 | $28.01 | $2.8K |
| 24.03.11 | SELL | ARKG | 404 | $28.37 | $11.5K |
| 24.03.08 | SELL | ARKG | 5,853 | $27.22 | $159.3K |
| 24.03.05 | SELL | ARKG | 28,235 | $26.08 | $736.4K |
| 24.03.04 | SELL | ARKG | 84,636 | $25.89 | $2.2M |
| 24.01.16 | SELL | ARKG | 337,517 | $28.32 | $9.6M |
Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.
Based on ARK ETF real-time + 13F quarterly filings
13F data may be delayed up to 90 days.
Analyst Consensus
※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.
Price Information
Trading Volume
Valuation
Financials
Profitability
Dividend
Technical
Pfizer Inc. is a global biopharmaceutical company that discovers, develops, manufactures, and sells a wide range of medicines and vaccines across various therapeutic areas, including cardiovascular, infectious diseases, and COVID-19. Their product portfolio includes well-known brands like Eliquis, Prevnar, Comirnaty, and Paxlovid, positioning them as a major player in the pharmaceutical industry. Pfizer also engages in contract manufacturing and serves diverse healthcare channels.
AI-generated summary. Not investment advice.
Related ARK stocks
Explore companies with similar themes or neighboring ARK trading activity.